Psychotherapists

For Everyone

Drug Developers

About

ON-DEMAND

Loading description...
Loading...

6 Hours

On-Demand

6 Hours CE Credits

Loading...
Flexible payment options available at checkout

ON-DEMAND

Loading description...
Loading...

6 Hours

On-Demand

6 Hours CE Credits

Loading...
Flexible payment options available at checkout

ON-DEMAND

Loading description...
Loading...

6 Hours

On-Demand

6 Hours CE Credits

Loading...
Flexible payment options available at checkout

Play Trailer

Overview

About

Learning Objectives

Continuing Education

Legality

Badges

What to Expect from This Course

This second part of the Introduction to Psychedelic Therapy series deepens your understanding of clinical applications and harm reduction principles across key psychedelic substances. Building on the foundational knowledge established, this course introduces practical frameworks for working with clients.

Learners will explore the Psychedelic Harm Reduction and Integration (PHRI) model and its application to real-world care. Through focused modules on ketamine, psilocybin, and MDMA, participants will gain insight into therapeutic mechanisms, session structure, client preparation, and ethical considerations. The course emphasizes the importance of trauma-informed practice, safety, and integration across diverse treatment contexts.

The course includes 6 hours of video content across two in-depth chapters and is entirely self-paced. It serves as the second part of a two-part educational sequence.

Topics Covered

PHRI Fundamentals

  • Key principles and theoretical underpinnings of the PHRI model

  • Distinctions between preparation, assessment, and integration

  • Strategies for applying PHRI in clinical and community settings

Ketamine

  • Mechanisms of action and subjective effects

  • Clinical uses of Ketamine-Assisted Psychotherapy (KAP)

  • Ethical, structural, and therapeutic considerations in practice

Psilocybin

  • Historical and contemporary research foundations

  • Subjective experience and therapeutic outcomes

  • Clinical applications and integration into PHRI practices

  • Comparative perspectives: clinical trials, state-regulated models, and facilitator-led sessions

MDMA

  • Development and clinical application of MDMA-assisted therapy (MDMA-AT)

  • Mechanisms of action and psychotherapeutic models

  • Practical and ethical implications for future mental health integration

Badge

Course Publication & Review Dates

April 14, 2025

Type

On-Demand

Topic Area & Instructional Level

Clinical Practice

Introductory

Who Should Attend? Psychologists, counselors, masters or doctoral level clinical social workers, marriage and family therapists, and other medical professionals.

Completion Requirements: To receive a certificate of completion with CE information included students must complete all course sessions and modules, and obtain a score of 75% or higher on course completion quizzes. Upon completion of the course trainees are provided an evaluation form. For on-demand courses (recorded asynchronous distance learning), students will be able to access/download their certificate after marking all modules “complete.” 

System Requirements: To access our on-demand classroom, we recommend using a desktop or laptop with the latest version of Chrome, Firefox, Safari, or Edge, and a stable internet connection for the best learning experience.

Financial Support & Conflict of Interest Statements: Fluence pays course trainers for their teaching. There is no other financial support for the development of this course. There is no potential conflict of interest or outside commercial support for this course.

Other: Click here to see our policies on attendance, refunds, grievances, and accessibility. Click here to see our frequently asked questions. Click here to contact us or submit a grievance. For any inquiries related to subject matter guidance, correction, grading, comments, or problem resolution please contact us.

More Info

Overview

About

Learning Objectives

Continuing Education

Legality

Badges

What to Expect from This Course

This second part of the Introduction to Psychedelic Therapy series deepens your understanding of clinical applications and harm reduction principles across key psychedelic substances. Building on the foundational knowledge established, this course introduces practical frameworks for working with clients.

Learners will explore the Psychedelic Harm Reduction and Integration (PHRI) model and its application to real-world care. Through focused modules on ketamine, psilocybin, and MDMA, participants will gain insight into therapeutic mechanisms, session structure, client preparation, and ethical considerations. The course emphasizes the importance of trauma-informed practice, safety, and integration across diverse treatment contexts.

The course includes 6 hours of video content across two in-depth chapters and is entirely self-paced. It serves as the second part of a two-part educational sequence.

Topics Covered

PHRI Fundamentals

  • Key principles and theoretical underpinnings of the PHRI model

  • Distinctions between preparation, assessment, and integration

  • Strategies for applying PHRI in clinical and community settings

Ketamine

  • Mechanisms of action and subjective effects

  • Clinical uses of Ketamine-Assisted Psychotherapy (KAP)

  • Ethical, structural, and therapeutic considerations in practice

Psilocybin

  • Historical and contemporary research foundations

  • Subjective experience and therapeutic outcomes

  • Clinical applications and integration into PHRI practices

  • Comparative perspectives: clinical trials, state-regulated models, and facilitator-led sessions

MDMA

  • Development and clinical application of MDMA-assisted therapy (MDMA-AT)

  • Mechanisms of action and psychotherapeutic models

  • Practical and ethical implications for future mental health integration

Course Badge

Course Publication & Review Dates

April 14, 2025

Type

On-Demand

Topic Area & Instructional Level

Clinical Practice

Introductory

Who Should Attend? Psychologists, counselors, masters or doctoral level clinical social workers, marriage and family therapists, and other medical professionals.

Completion Requirements: To receive a certificate of completion with CE information included students must complete all course sessions and modules, and obtain a score of 75% or higher on course completion quizzes. Upon completion of the course trainees are provided an evaluation form. For on-demand courses (recorded asynchronous distance learning), students will be able to access/download their certificate after marking all modules “complete.” 

System Requirements: To access our on-demand classroom, we recommend using a desktop or laptop with the latest version of Chrome, Firefox, Safari, or Edge, and a stable internet connection for the best learning experience.

Financial Support & Conflict of Interest Statements: Fluence pays course trainers for their teaching. There is no other financial support for the development of this course. There is no potential conflict of interest or outside commercial support for this course.

Other: Click here to see our policies on attendance, refunds, grievances, and accessibility. Click here to see our frequently asked questions. Click here to contact us or submit a grievance. For any inquiries related to subject matter guidance, correction, grading, comments, or problem resolution please contact us.

More Info

Overview

About

Learning Objectives

Continuing Education

Legality

Badges

What to Expect from This Course

This second part of the Introduction to Psychedelic Therapy series deepens your understanding of clinical applications and harm reduction principles across key psychedelic substances. Building on the foundational knowledge established, this course introduces practical frameworks for working with clients.

Learners will explore the Psychedelic Harm Reduction and Integration (PHRI) model and its application to real-world care. Through focused modules on ketamine, psilocybin, and MDMA, participants will gain insight into therapeutic mechanisms, session structure, client preparation, and ethical considerations. The course emphasizes the importance of trauma-informed practice, safety, and integration across diverse treatment contexts.

The course includes 6 hours of video content across two in-depth chapters and is entirely self-paced. It serves as the second part of a two-part educational sequence.

Topics Covered

PHRI Fundamentals

  • Key principles and theoretical underpinnings of the PHRI model

  • Distinctions between preparation, assessment, and integration

  • Strategies for applying PHRI in clinical and community settings

Ketamine

  • Mechanisms of action and subjective effects

  • Clinical uses of Ketamine-Assisted Psychotherapy (KAP)

  • Ethical, structural, and therapeutic considerations in practice

Psilocybin

  • Historical and contemporary research foundations

  • Subjective experience and therapeutic outcomes

  • Clinical applications and integration into PHRI practices

  • Comparative perspectives: clinical trials, state-regulated models, and facilitator-led sessions

MDMA

  • Development and clinical application of MDMA-assisted therapy (MDMA-AT)

  • Mechanisms of action and psychotherapeutic models

  • Practical and ethical implications for future mental health integration

Course Badge

Course Publication & Review Dates

April 14, 2025

Type

On-Demand

Topic Area & Instructional Level

Clinical Practice

Introductory

Who Should Attend? Psychologists, counselors, masters or doctoral level clinical social workers, marriage and family therapists, and other medical professionals.

Completion Requirements: To receive a certificate of completion with CE information included students must complete all course sessions and modules, and obtain a score of 75% or higher on course completion quizzes. Upon completion of the course trainees are provided an evaluation form. For on-demand courses (recorded asynchronous distance learning), students will be able to access/download their certificate after marking all modules “complete.” 

System Requirements: To access our on-demand classroom, we recommend using a desktop or laptop with the latest version of Chrome, Firefox, Safari, or Edge, and a stable internet connection for the best learning experience.

Financial Support & Conflict of Interest Statements: Fluence pays course trainers for their teaching. There is no other financial support for the development of this course. There is no potential conflict of interest or outside commercial support for this course.

Other: Click here to see our policies on attendance, refunds, grievances, and accessibility. Click here to see our frequently asked questions. Click here to contact us or submit a grievance. For any inquiries related to subject matter guidance, correction, grading, comments, or problem resolution please contact us.

More Info

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

Grow your practice.

Get certified and join the Fluence Psychedelic Therapy Directory—where clients find trusted experts.

What students have to say about our programs...

  • I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

    Amy Johnson

    LCSW

  • I've been more than thrilled about my experience with Fluence thus far. I am a ketamine-assisted psychotherapist and

    continue to learn more information and modalities to incorporate into my practice, from both the instructors and

    fellow students.

    LAURA HUTCHINS,

    LCMHC, LCAS, KAP Consulting

  • My entire experience with Fluence has been exceptional. The instructors are giants in the psychedelic field, many are active in clinical research and you will see their names in scientific publications.

    Stephanie Barss,

    FNP, PMHNP, Psilocybin-Assisted Therapy

    Certificate Program Advisor

  • The trainers at Fluence are what continually confirm that I am in the right place. The reverence and honor with which they approach their work is so evident. I have felt a sense of safety

    at Fluence that is not present in other organizations I have

    trained with or researched, and it is the trainers who create that safety.

    Andrea Bigenho,

    LPC specialist in Psychedelic Integration

What are students say…

I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,

LCSW

What students have to say about our programs...

I really appreciate Fluence. The trainings and coursework, the literature shared, the community, self-development and insightful explorations have strengthened me as a professional and given such a sense of competence in this evolving space.

Amy Johnson,

LCSW

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.

Authorized provider of continuing education.

Fluence is approved by the American Psychological Association to sponsor continuing education for psychologists.

Fluence maintains responsibility for this program and its content.

Have questions? Ask our experts.

Have questions?
Ask our experts.

Have questions? Ask our experts.